Actively Recruiting
Ocular Perfusion in Patients With Idiopathic Intracranial Hypertension
Led by Medical University of Vienna · Updated on 2024-08-30
48
Participants Needed
1
Research Sites
117 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The proposed study aims to evaluate optic nerve head blood flow and microcirculation in patients with idiopathic intracranial hypertension. For this purpose, optic nerve head blood flow will be examined in patients with IIH before and after therapy and additionally compared with healthy age- and sex-matched control subjects. In addition, other parameters will be measured, in particular retinal blood flow, retinal oxygen saturation and retinal neurovascular coupling.
CONDITIONS
Official Title
Ocular Perfusion in Patients With Idiopathic Intracranial Hypertension
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Men and women aged 18 years or older
- Signed informed consent
- Newly diagnosed idiopathic intracranial hypertension or relapse of idiopathic intracranial hypertension
- Non-smokers
- Men and women aged 18 years or older
- Signed informed consent
- Normal eye exam findings unless considered clinically irrelevant by the investigator
- Normal medical history unless considered clinically irrelevant by the investigator
- Non-smokers
You will not qualify if you...
- Blood donation in the three weeks before the study
- Symptoms of a clinically relevant illness in the three weeks before the study
- Eye inflammation or infection within the last 3 months
- Personal or family history of epilepsy
- Diabetes mellitus type 1 or type 2
- History or presence of cerebral vascular diseases like arteriovenous malformation, aneurysm, or major artery problems
- History or presence of intracranial infections such as meningitis
- History or presence of other neurological diseases including brain tumor, hydrocephalus, or degenerative diseases
- Use of corticosteroids or immunosuppressant therapy
- Pregnant or breastfeeding women
- Women of childbearing potential not using effective contraception and who are neither menopausal, hysterectomized, nor sterilized
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Medical University of Vienna
Vienna, Austria, 1090
Actively Recruiting
Research Team
G
Gerhard Garhöfer
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here